CN116115677A - Moxa stick for smart turtle moxibustion technology and preparation method thereof - Google Patents
Moxa stick for smart turtle moxibustion technology and preparation method thereof Download PDFInfo
- Publication number
- CN116115677A CN116115677A CN202310104756.XA CN202310104756A CN116115677A CN 116115677 A CN116115677 A CN 116115677A CN 202310104756 A CN202310104756 A CN 202310104756A CN 116115677 A CN116115677 A CN 116115677A
- Authority
- CN
- China
- Prior art keywords
- parts
- moxa
- moxa stick
- moxibustion
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
- A61H39/06—Devices for heating or cooling such points within cell-life limits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The invention discloses a moxa stick for a tortoise moxibustion technique and a preparation method thereof, wherein the moxa stick comprises the following raw materials in parts by mass: 100 parts of moxa, 20-50 parts of golden moxa, 10 parts of salted eucommia bark, 10-23 parts of bran-fried fructus aurantii, 10-35 parts of asarum, 20-36 parts of radix angelicae pubescentis, 50-70 parts of elecampane, 35-45 parts of cinnamon and 15 parts of Chinese angelica; the invention further provides a processing method of the tortoise moxibustion moxa stick, and the tortoise moxibustion moxa stick matched with the tortoise moxibustion technology prepared by the invention is particularly suitable for treating diseases of people with syndrome differentiation and yin syndrome, and aims at trunk and limb diseases: headache, arthralgia, remote and spasmodic mouth, and accumulation; heart and brain disease pattern: apoplexy, dizziness, insomnia, depression, consumptive disease, palpitation, chest stuffiness (except for true heart pain), heart failure (except for acute phase), hyperhidrosis, flaccidity disease, epilepsy, and syncope in remission stage, has effects of dredging meridian passage, regulating qi-flowing for tranquillization, and can be used for treating deficiency syndrome, cold syndrome, arthralgia syndrome and pain syndrome, promoting blood circulation for relieving pain, dispelling cold and resisting fatigue.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicine compositions, in particular to a moxa stick for a tortoise moxibustion technique and a preparation method thereof.
Background
The moxa stick disclosed by the prior art belongs to an auxiliary means in rehabilitation therapy, does not have a medical knowledge system for specific symptoms and is matched with clinical practice to make traditional Chinese medicine treatment means for directional therapy on specific physical symptoms, most of the existing moxa sticks stay on warming bodies to relieve fatigue, and the moxa stick disclosed by the prior art is particularly suitable for treating diseases of patients with syndrome differentiation of yin syndromes, and aims at trunk and limb diseases: headache, arthralgia, remote and spasmodic mouth, and accumulation; heart and brain disorders: the preparation method has the advantages that the functions of the Chinese medicinal materials are furthest exerted, the medicinal effects are reserved, and the internal component structures of the Chinese medicinal materials are furthest reserved by utilizing a microwave drying technology and a far infrared technology, so that the clinical experimental treatment effect of the tortoise moxibustion technology is furthest presented.
Disclosure of Invention
The invention aims to solve the technical problems and provides a moxa stick for a tortoise moxibustion technology and a preparation method thereof. The technical scheme of the invention is realized as follows: a moxa stick for moxibustion of tortoise and its preparation method are provided, which comprises moxa, gold moxa, herba Agastaches, spina Gleditsiae, rhizoma Ligustici Chuanxiong, vinegar myrrha, flos Caryophylli, ramulus Cinnamomi, salted Eucommiae cortex, parched fructus Aurantii, herba asari, radix Angelicae Pubescentis, radix aucklandiae, continuous fragment, salted Achyranthis radix, radix Stephaniae Tetrandrae, cortex Cinnamomi, and radix Angelicae sinensis.
In order to solve the problems, the invention provides a tortoise moxibustion moxa stick which comprises the following raw materials in parts by weight:
moxa 100 parts
20-50 parts of golden moxa
53-70 parts of patchouli
16-55 parts of spina gleditsiae
13-30 parts of szechuan lovage rhizome
27-53 parts of vinegar myrrh
50-66 parts of clove
10 parts of cassia twig
Salted eucommia bark 10 parts
Bran-fried bitter orange 10-23 parts
Asarum herb 10-35 parts
20-36 parts of radix angelicae pubescentis
50-70 parts of costustoot
10 parts of continuous fragment
33-50 parts of salted achyranthes root
Radix stephaniae tetrandrae 30-50 parts
35-45 parts of cinnamon
15 parts of Chinese angelica
The invention aims at solving the technical scheme that the processing method of the moxibustion moxa stick for the tortoise is provided, and the method for preparing the moxa stick by combining the 16 traditional Chinese medicinal materials does not exist at present aiming at deficiency syndrome, cold syndrome, arthralgia syndrome and pain syndrome of the disease of the syndrome differentiation of yin syndrome.
In order to solve the problems, the invention provides a processing method of the tortoise moxibustion moxa stick, which comprises the following steps:
preparing a Z1 raw material: sorting herba Agastaches, spina Gleditsiae, rhizoma Ligustici Chuanxiong, vinegar myrrha, flos Caryophylli, ramulus Cinnamomi, salted Eucommiae cortex, fructus Aurantii parched with bran, herba asari, radix Angelicae Pubescentis, radix aucklandiae, rhizoma Sparganii, radix Achyranthis bidentatae, radix Stephaniae Tetrandrae, cortex Cinnamomi, and radix Angelicae sinensis according to medicinal properties, firstly, slicing rhizoma Ligustici Chuanxiong, ramulus Cinnamomi, fructus Aurantii parched with bran, herba asari, radix Angelicae Pubescentis, radix aucklandiae, rhizoma Sparganii, radix Achyranthis bidentatae, radix Stephaniae Tetrandrae, and radix Angelicae sinensis, mixing with herba Agastaches, spina Gleditsiae, salted Eucommiae cortex, and cortex Cinnamomi, secondly, squeezing rhizoma Ligustici Chuanxiong, ramulus Cinnamomi, bran-parched fructus Aurantii, herba asari, radix Angelicae Pubescentis, radix aucklandiae, rhizoma Sparganii, radix Achyranthis bidentatae, radix Stephaniae, and radix Angelicae sinensis, the preparation method comprises the steps of carrying out microwave drying technology on patchouli and spina gleditsiae to reduce the water content to 6%, carrying out extrusion process, carrying out 50-degree drying on salted eucommia ulmoides and cinnamon, carrying out extrusion process, carrying out third step, grinding patchouli, spina gleditsiae, ligusticum wallichii, cassia twig, salted eucommia ulmoides, bran-fried fructus aurantii, asarum, radix angelicae pubescentis, elecampane, continuous fragments, salted achyranthes root, radix stephaniae tetrandrae, cinnamon and angelica into particles, simultaneously carrying out low-temperature drying on the water content of the vinegar myrrh and the clove to 9% by using far infrared technology, carrying out grinding into particles, carrying out fourth step, grinding the traditional Chinese medicinal materials into powder, carrying out stirring in fifth step to finely divide the traditional Chinese medicinal materials, carrying out subpackaging according to the medicine name, and carrying out seventh step, and filtering by using a 120-mesh filter screen.
Z2 medicinal material humidity treatment: in the step Z1, the salted eucommia bark and the cinnamon are dried at 50 degrees, the patchouli and the spina gleditsiae are dried by a microwave drying technology, and the vinegar myrrh and the clove are dried at a low temperature by a far infrared technology.
And Z3, raw material compatibility: mixing the traditional Chinese medicine powder prepared in the step Z1 with moxa in a proportion of 1:9, wherein the proportion of the gold moxa is 20:1, proportioning.
Z4 moxa stick preparation: and (3) fully mixing the medicinal material powder obtained in the step Z1 and the step Z3 with moxa and gold moxa, and then filling and extruding the mixture into strips by a filling machine.
Z5 storage treatment: and (5) placing the dried strips in a drying space after the strips are formed, and storing the strips at constant temperature.
And in the step Z1, the vinegar myrrh and the clove are dried at a low temperature by using a far infrared technology, the moisture is reduced to 9%, the patchouli and the spina gleditsiae are dried by using a microwave drying technology, the moisture is reduced to 6%, and then the vinegar myrrh, the clove, the patchouli and the spina gleditsiae Chinese medicinal materials with high medicinal effect integrity are obtained by extrusion.
When 16 traditional Chinese medicinal materials in the step Z1 reach the fifth step in the step Z1, the powdery traditional Chinese medicinal materials with the diameters of 80-100um and 5-10um are obtained through stirring and thickness division.
When 16 traditional Chinese medicinal materials in the step Z1 reach the seventh step in the step Z1, a 120-mesh filter screen is adopted to filter the traditional Chinese medicinal materials, so that the traditional Chinese medicinal powder with the required precision of 0.125 mm is obtained.
The water content of the traditional Chinese medicinal materials is controlled to be within 9% before the step Z3 is started, and the drying method is far infrared technology low-temperature drying and microwave drying, and 50-degree drying.
And Z4, fully mixing the traditional Chinese medicine powder with moxa and gold moxa, filling the mixture in a filling machine, and extruding the mixture into strip-shaped sealing edges by matching with an extruder after dust-free treatment.
Drawings
FIG. 1 is a schematic flow chart of the preparation process of the present invention.
Detailed Description
The present application is described in further detail below with reference to examples. It is to be understood that the specific embodiments described herein are merely illustrative of the relevant invention and not limiting of the invention, and that the embodiments and features of the embodiments herein may be combined with each other without conflict.
The beneficial effects of the invention are as follows: the pure traditional Chinese medicine smart turtle moxibustion moxa stick and smart turtle moxibustion technology is particularly suitable for treating diseases of people with syndrome differentiation of yin syndromes, and aims at body and limb diseases: headache, arthralgia, remote and spasmodic mouth, and accumulation; heart and brain disorders: the specific examples described herein are intended to illustrate the invention and are not intended to limit the invention, as stroke, dizziness, insomnia, depression, consumptive disease, palpitations, chest impediment (except for pain in the heart), heart failure (except for acute phase), hyperhidrosis, flaccidity, epilepsy, and remission of syncope. Referring to fig. 1, the present invention provides a preparation method of moxa sticks for a tortoise moxibustion technique, which comprises the following steps:
preparing a Z1 raw material: sorting herba Agastaches, spina Gleditsiae, rhizoma Ligustici Chuanxiong, vinegar myrrha, flos Caryophylli, ramulus Cinnamomi, salted Eucommiae cortex, fructus Aurantii parched with bran, herba asari, radix Angelicae Pubescentis, radix aucklandiae, rhizoma Sparganii, radix Achyranthis bidentatae, radix Stephaniae Tetrandrae, cortex Cinnamomi, and radix Angelicae sinensis according to medicinal properties, firstly, slicing rhizoma Ligustici Chuanxiong, ramulus Cinnamomi, fructus Aurantii parched with bran, herba asari, radix Angelicae Pubescentis, radix aucklandiae, rhizoma Sparganii, radix Achyranthis bidentatae, radix Stephaniae Tetrandrae, and radix Angelicae sinensis, mixing with herba Agastaches, spina Gleditsiae, salted Eucommiae cortex, and cortex Cinnamomi, secondly, squeezing rhizoma Ligustici Chuanxiong, ramulus Cinnamomi, bran-parched fructus Aurantii, herba asari, radix Angelicae Pubescentis, radix aucklandiae, rhizoma Sparganii, radix Achyranthis bidentatae, radix Stephaniae, and radix Angelicae sinensis, the preparation method comprises the steps of carrying out microwave drying technology on patchouli and spina gleditsiae to reduce the water content to 6%, carrying out extrusion process, carrying out 50-degree drying on salted eucommia ulmoides and cinnamon, carrying out extrusion process, carrying out third step, grinding patchouli, spina gleditsiae, ligusticum wallichii, cassia twig, salted eucommia ulmoides, bran-fried fructus aurantii, asarum, radix angelicae pubescentis, elecampane, continuous fragments, salted achyranthes root, radix stephaniae tetrandrae, cinnamon and angelica into particles, simultaneously carrying out low-temperature drying on the water content of the vinegar myrrh and the clove to 9% by using far infrared technology, carrying out grinding into particles, carrying out fourth step, grinding the traditional Chinese medicinal materials into powder, carrying out stirring in fifth step to finely divide the traditional Chinese medicinal materials, carrying out subpackaging according to the medicine name, and carrying out seventh step, and filtering by using a 120-mesh filter screen.
Z2 medicinal material humidity treatment: in the step Z1, the salted eucommia bark and the cinnamon are dried at 50 degrees, the patchouli and the spina gleditsiae are dried by a microwave drying technology, and the vinegar myrrh and the clove are dried at a low temperature by a far infrared technology.
And Z3, raw material compatibility: mixing the traditional Chinese medicine powder prepared in the step Z1 with moxa in a proportion of 1:9, wherein the proportion of the gold moxa is 20:1, proportioning.
Z4 moxa stick preparation: and (3) fully mixing the medicinal material powder obtained in the step Z1 and the step Z3 with moxa and gold moxa, and then filling and extruding the mixture into strips by a filling machine.
Z5 storage treatment: and (5) placing the dried strips in a drying space after the strips are formed, and storing the strips at constant temperature.
Clinical observation:
(1) Clinical data: the inventors performed clinical observation treatment on 60 patients, 30 cases each for men and women.
The treatment method comprises the following steps: according to the differentiation of viscera and meridians, the corresponding treatment positions of the diseased viscera or meridians in the eight diagrams of the abdomen are selected, the positions of the acupoints are in accordance with the specification of GB/T12346-2006, and the operation positions are all the abdomen, so the supine position is selected, and Ai Tiaogao degrees are adopted when moxibustion is applied: the temperature of the skin at the moxibustion position of the patient and the temperature sensed by the hands of the doctor are suitable, the hanging height of the moxa stick is 10-20 cm, and the moxa stick is adjusted up and down along with the temperature change in the moxibustion process, if a person with sensory disorder is located, the temperature sensed by the hands of the doctor is used as the main temperature, so that low-temperature scalding is prevented, and the mild moxibustion is performed: the moxa stick is held by a user, the hand is pressed and is fixed on the moxibustion part, the burning end of the moxa stick is suspended on the moxibustion part 10-20 cm away from the skin, and the moxibustion is carried out at fixed points, the heat is mild, so that the skin has warm sensation and no burning pain; and (3) rotary moxibustion: the moxa stick is held by the operator, the hand is pressed and is fixed on the moxibustion part, the burning end of the moxa stick is suspended on the moxibustion part 10-20 cm away from the skin, and the moxa stick is spirally and reciprocally fumigated and moxibustion in parallel, the heat is mainly mild, so that the skin has warm sensation and no burning pain; sparrow pecking moxibustion: the moxa stick is held by a user, the hand is pressed and is lightly placed and fixed on a moxibustion part, the burning end of the moxa stick is suspended on the moxibustion part at a position 10-20 cm away from the skin, and the moxa stick is aligned to an acupoint and moves up and down, so that the moxa stick is like a bird pecking sample, and the moxa stick is applied by negligence and negligence, the heat is mild, the skin is warm and has no burning pain, near infrared has stronger capability of penetrating the skin of a human body, the penetration depth is about 10mm generally, and far infrared penetrates into the skin of the human body to 1mm; spectrum of radiation emitted when moxa burns.
According to the patient's illness state and tolerance, proper moxibustion amount is selected, one part is used for moxibustion for 20-30 minutes, one part is used for moxibustion every day, one part is used for moxibustion every other day or 3-5 days, one part is used for moxibustion for stable illness state, one treatment course is used for moxibustion for 5-7 times, and the amount of moxibustion is reduced properly for children until the skin is red or warm and comfortable.
(2) The treatment effect judgment standard is based on the treatment effect evaluation standard of ' indication ' in the treatment effect standard (2012 edition) of medical evidence diagnosis in the Chinese people's republic of China written by the medical administration of China, namely, the treatment effect judgment standard is that all laboratory examination data of curing symptoms are normal, improvement is that the time for relieving the symptoms is shortened or the period is prolonged, and the laboratory examination data are improved, namely, the treatment effect judgment standard is invalid, and the laboratory examination data are unchanged.
And (3) curing: trunk and limb disorders: headache, arthralgia, remote and spasmodic mouth, and accumulation; heart and brain diseases: laboratory examination data of symptoms of apoplexy, dizziness, insomnia, melancholia, consumptive disease, palpitation, chest stuffiness (except for true heart pain), heart failure (except for acute phase), hyperhidrosis, flaccidity disease, epilepsy and remission stage of syncope disease are normal;
improvement: trunk and limb disorders: headache, arthralgia, remote and spasmodic mouth, and accumulation; heart and brain diseases: the symptoms of apoplexy, dizziness, insomnia, depression, consumptive disease, palpitation, chest stuffiness (except for true heart pain), heart failure (except for acute phase), hyperhidrosis, flaccidity disease, epilepsy and syncope in remission stage are reduced, the attack time is shortened or the period is prolonged;
invalidation: checking and comparing before and after treatment, and ensuring that the function, symptoms, signs, symptoms and laboratory checking data are unchanged;
(3) Clinical results: clinical cure rate (total effective rate) =cure+improvement/total patient.
Embodiment one: the embodiment provides a moxa stick for a tortoise moxibustion technique, wherein the moxa stick comprises the following raw material medicines in parts by weight: 100 parts of moxa, 20-50 parts of golden moxa, 53-70 parts of patchouli, 16-55 parts of spina gleditsiae, 13-30 parts of ligusticum wallichii, 27-53 parts of vinegar myrrh, 50-66 parts of clove, 10 parts of cassia twig, 10 parts of salted eucommia bark, 10-23 parts of bran-fried bitter orange, 10-35 parts of asarum, 20-36 parts of radix angelicae pubescentis, 50-70 parts of radix aucklandiae, 10 parts of fragment of continuous, 33-50 parts of salted achyranthes root, 30-50 parts of radix stephaniae tetrandrae, 35-45 parts of cinnamon and 15 parts of angelica sinensis. The preparation method comprises the steps of drying, extruding, grinding, stirring, filtering and mixing uniformly to prepare required powder, and filling the powder into moxa stick paper made of mulberry paper and extruding the moxa stick paper into strips to obtain the tortoise moxibustion moxa stick for mainly treating deficiency syndrome, cold syndrome, arthralgia syndrome and pain syndrome. The clinical observations of this example were: 40 cases (66%) are clinically cured, 9 cases (15%) are improved, 11 cases (18%) are not effective, and the clinical cure rate (total effective rate) is 81%.
Embodiment two: the embodiment provides a moxa stick for a tortoise moxibustion technique, wherein the moxa stick comprises the following raw material medicines in parts by weight: 100 parts of moxa, 10-40 parts of golden moxa, 40-55 parts of patchouli, 10-35 parts of spina gleditsiae, 14-26 parts of ligusticum wallichii, 12-45 parts of vinegar myrrh, 40-55 parts of clove, 13 parts of cassia twig, 15 parts of salted eucommia bark, 12-26 parts of bran-fried bitter orange, 13-25 parts of asarum, 10-23 parts of radix angelicae pubescentis, 35-50 parts of radix aucklandiae, 10 parts of teasel root slices, 20-30 parts of salted achyranthes root, 28-40 parts of radix stephaniae tetrandrae, 20-40 parts of cinnamon and 10 parts of angelica sinensis. The preparation method comprises the steps of drying, extruding, grinding, stirring, filtering and mixing uniformly to prepare required powder, and filling the powder into moxa stick paper made of mulberry paper and extruding the moxa stick paper into strips to obtain the tortoise moxibustion moxa stick for mainly treating deficiency syndrome, cold syndrome, arthralgia syndrome and pain syndrome. The clinical observation method is the same as that of the example, and the clinical observation result of the example is as follows: 51 cases (85%) are clinically cured, 2 cases (3%) are improved, 7 cases (11%) are not effective, and the clinical cure rate (total effective rate) is 88%.
Embodiment III: the embodiment provides a moxa stick for a tortoise moxibustion technique, wherein the moxa stick comprises the following raw material medicines in parts by weight: 100 parts of moxa, 30-50 parts of golden moxa, 66-75 parts of patchouli, 38-55 parts of spina gleditsiae, 23-42 parts of ligusticum wallichii, 40-75 parts of vinegar myrrh, 60-82 parts of clove, 20 parts of cassia twig, 20 parts of salted eucommia bark, 35-40 parts of bran-fried bitter orange, 23-44 parts of asarum, 47-60 parts of radix angelicae pubescentis, 70-82 parts of elecampane, 20 parts of teasel root slices, 46-55 parts of salted achyranthes root, 40-62 parts of radix stephaniae tetrandrae, 52-68 parts of cinnamon and 20 parts of angelica sinensis. The preparation method comprises the steps of drying, extruding, grinding, stirring, filtering and mixing uniformly to prepare required powder, and filling the powder into moxa stick paper made of mulberry paper and extruding the moxa stick paper into strips to obtain the tortoise moxibustion moxa stick for mainly treating deficiency syndrome, cold syndrome, arthralgia syndrome and pain syndrome. The clinical observation method is the same as that of the first embodiment. The clinical observations of this example were: 50 cases (83%) of clinical cure, 4 cases (6%) of improvement, 6 cases (10%) of invalidation, and the clinical cure rate (total effective rate) was 90%.
The moxa stick and the preparation method thereof provided by the invention have obvious effects on deficiency syndrome, cold syndrome, arthralgia syndrome and pain syndrome caused by yin syndrome differentiation. The technical scheme of the invention is not limited to the specific embodiment, and all technical modifications made according to the technical scheme of the invention fall within the protection scope of the invention.
Claims (9)
1. A moxa stick for a tortoise moxibustion technique and a preparation method thereof are characterized in that: the material comprises the following raw materials in parts by weight: 100 parts of moxa, 20-50 parts of golden moxa, 53-70 parts of patchouli, 16-55 parts of spina gleditsiae, 13-30 parts of ligusticum wallichii, 27-53 parts of vinegar myrrh, 50-66 parts of clove, 10 parts of cassia twig, 10 parts of salted eucommia bark, 10-23 parts of bran-fried bitter orange, 10-35 parts of asarum, 20-36 parts of radix angelicae pubescentis, 50-70 parts of radix aucklandiae, 10 parts of fragment of continuous, 33-50 parts of salted achyranthes root, 30-50 parts of radix stephaniae tetrandrae, 35-45 parts of cinnamon and 15 parts of angelica sinensis.
2. The moxa stick for the smart turtle moxibustion technology and the preparation method thereof according to claim 1, wherein the moxa stick is characterized in that: the preparation method comprises the following raw materials: 100 parts of moxa, 10-40 parts of golden moxa, 40-55 parts of patchouli, 10-35 parts of spina gleditsiae, 14-26 parts of ligusticum wallichii, 12-45 parts of vinegar myrrh, 40-55 parts of clove, 13 parts of cassia twig, 15 parts of salted eucommia bark, 12-26 parts of bran-fried bitter orange, 13-25 parts of asarum, 10-23 parts of radix angelicae pubescentis, 35-50 parts of radix aucklandiae, 10 parts of teasel root slices, 20-30 parts of salted achyranthes root, 28-40 parts of radix stephaniae tetrandrae, 20-40 parts of cinnamon and 10 parts of angelica sinensis.
3. The moxa stick for the smart turtle moxibustion technology and the preparation method thereof according to claim 1, wherein the moxa stick is characterized in that: the preparation method comprises the following raw materials: 100 parts of moxa, 30-50 parts of golden moxa, 66-75 parts of patchouli, 38-55 parts of spina gleditsiae, 23-42 parts of ligusticum wallichii, 40-75 parts of vinegar myrrh, 60-82 parts of clove, 20 parts of cassia twig, 20 parts of salted eucommia bark, 35-40 parts of bran-fried bitter orange, 23-44 parts of asarum, 47-60 parts of radix angelicae pubescentis, 70-82 parts of elecampane, 20 parts of teasel root slices, 46-55 parts of salted achyranthes root, 40-62 parts of radix stephaniae tetrandrae, 52-68 parts of cinnamon and 20 parts of angelica sinensis.
4. A preparation method of moxa sticks for a tortoise moxibustion technique is characterized by comprising the following steps: the method comprises the following steps: preparing a Z1 raw material: sorting herba Agastaches, spina Gleditsiae, rhizoma Ligustici Chuanxiong, vinegar myrrha, flos Caryophylli, ramulus Cinnamomi, salted Eucommiae cortex, fructus Aurantii parched with bran, herba asari, radix Angelicae Pubescentis, radix aucklandiae, rhizoma Sparganii, radix Achyranthis bidentatae, radix Stephaniae Tetrandrae, cortex Cinnamomi, and radix Angelicae sinensis according to medicinal properties, firstly, slicing rhizoma Ligustici Chuanxiong, ramulus Cinnamomi, fructus Aurantii parched with bran, herba asari, radix Angelicae Pubescentis, radix aucklandiae, rhizoma Sparganii, radix Achyranthis bidentatae, radix Stephaniae Tetrandrae, and radix Angelicae sinensis, mixing with herba Agastaches, spina Gleditsiae, salted Eucommiae cortex, and cortex Cinnamomi, secondly, squeezing rhizoma Ligustici Chuanxiong, ramulus Cinnamomi, bran-parched fructus Aurantii, herba asari, radix Angelicae Pubescentis, radix aucklandiae, rhizoma Sparganii, radix Achyranthis bidentatae, radix Stephaniae, and radix Angelicae sinensis, the preparation method comprises the steps of carrying out microwave drying technology on patchouli and spina gleditsiae to reduce the water content to 6%, carrying out extrusion process, carrying out 50-degree drying on salted eucommia ulmoides and cinnamon, carrying out extrusion process, carrying out third step, grinding patchouli, spina gleditsiae, ligusticum wallichii, cassia twig, salted eucommia ulmoides, bran-fried fructus aurantii, asarum, radix angelicae pubescentis, elecampane, continuous fragments, salted achyranthes root, radix stephaniae tetrandrae, cinnamon and angelica into particles, simultaneously carrying out low-temperature drying on the water content of the vinegar myrrh and the clove to 9% by using far infrared technology, carrying out grinding into particles, carrying out fourth step, grinding the traditional Chinese medicinal materials into powder, carrying out stirring in fifth step to finely divide the traditional Chinese medicinal materials, carrying out subpackaging according to the medicine name, and carrying out seventh step, and filtering by using a 120-mesh filter screen.
Z2 medicinal material humidity treatment: in the step Z1, the salted eucommia bark and the cinnamon are dried at 50 degrees, the patchouli and the spina gleditsiae are dried by a microwave drying technology, and the vinegar myrrh and the clove are dried at a low temperature by a far infrared technology.
And Z3, raw material compatibility: mixing the traditional Chinese medicine powder prepared in the step Z1 with moxa in a proportion of 1:9, wherein the proportion of the gold moxa is 20:1, proportioning.
Z4 moxa stick preparation: and (3) fully mixing the medicinal material powder obtained in the step Z1 and the step Z3 with moxa and gold moxa, and then filling and extruding the mixture into strips by a filling machine.
Z5 storage treatment: and (5) placing the dried strips in a drying space after the strips are formed, and storing the strips at constant temperature.
5. The moxa stick for the smart turtle moxibustion technology and the preparation method thereof according to claim 4, wherein the moxa stick is characterized in that: in the step Z1, the vinegar myrrh and the clove are dried at a low temperature by using a far infrared technology, the moisture is reduced to 9%, the patchouli and the spina gleditsiae are dried by using a microwave drying technology, the moisture is reduced to 6%, and then the vinegar myrrh, the clove, the patchouli and the spina gleditsiae Chinese medicinal materials with high medicinal effect integrity are obtained by extrusion.
6. The moxa stick for the smart turtle moxibustion technology and the preparation method thereof according to claim 4, wherein the moxa stick is characterized in that: when 16 traditional Chinese medicinal materials in the step Z1 reach the fifth step in the step Z1, the powdery traditional Chinese medicinal materials with the diameters of 80-100um and 5-10um are obtained through stirring and thickness division.
7. The moxa stick for the smart turtle moxibustion technology and the preparation method thereof according to claim 4, wherein the moxa stick is characterized in that: when 16 traditional Chinese medicinal materials in the step Z1 reach the seventh step in the step Z1, a 120-mesh filter screen is adopted to filter the traditional Chinese medicinal materials, so that the traditional Chinese medicinal powder with the required precision of 0.125 mm is obtained.
8. The moxa stick for the smart turtle moxibustion technology and the preparation method thereof according to claim 4, wherein the moxa stick is characterized in that: the water content of the traditional Chinese medicinal materials is controlled to be within 9% before the step Z3 is started, and the drying method is far infrared technology low-temperature drying and microwave drying, and 50-degree drying.
9. The moxa stick for the smart turtle moxibustion technology and the preparation method thereof according to claim 4, wherein the moxa stick is characterized in that: and Z4, fully mixing the traditional Chinese medicine powder with moxa and gold moxa, filling the mixture in a filling machine, and extruding the mixture into strip-shaped sealing edges by matching with an extruder after dust-free treatment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310104756.XA CN116115677A (en) | 2023-02-09 | 2023-02-09 | Moxa stick for smart turtle moxibustion technology and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310104756.XA CN116115677A (en) | 2023-02-09 | 2023-02-09 | Moxa stick for smart turtle moxibustion technology and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116115677A true CN116115677A (en) | 2023-05-16 |
Family
ID=86295345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310104756.XA Pending CN116115677A (en) | 2023-02-09 | 2023-02-09 | Moxa stick for smart turtle moxibustion technology and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116115677A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110638987A (en) * | 2019-09-27 | 2020-01-03 | 贵州布依阿妈电子商务有限公司 | Moxibustion medicinal moxibustion stick for dispelling cold and eliminating dampness and preparation method thereof |
CN111202835A (en) * | 2020-03-25 | 2020-05-29 | 王泉蛟 | Vinasse traditional Chinese medicine bag for treating rheumatic arthralgia, lumbar muscle strain and joint injury |
CN113144128A (en) * | 2021-05-14 | 2021-07-23 | 王贵 | Pain-relieving plaster for treating arthralgia and myalgia |
CN113398165A (en) * | 2021-07-13 | 2021-09-17 | 孙永昌 | Traditional Chinese medicine composition for thunder-fire moxibustion, pharmaceutical preparation and preparation method thereof |
-
2023
- 2023-02-09 CN CN202310104756.XA patent/CN116115677A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110638987A (en) * | 2019-09-27 | 2020-01-03 | 贵州布依阿妈电子商务有限公司 | Moxibustion medicinal moxibustion stick for dispelling cold and eliminating dampness and preparation method thereof |
CN111202835A (en) * | 2020-03-25 | 2020-05-29 | 王泉蛟 | Vinasse traditional Chinese medicine bag for treating rheumatic arthralgia, lumbar muscle strain and joint injury |
CN113144128A (en) * | 2021-05-14 | 2021-07-23 | 王贵 | Pain-relieving plaster for treating arthralgia and myalgia |
CN113398165A (en) * | 2021-07-13 | 2021-09-17 | 孙永昌 | Traditional Chinese medicine composition for thunder-fire moxibustion, pharmaceutical preparation and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
广东省针灸学会: "岭南特色针灸技术操作规范:灵龟灸技术", vol. 2, pages 1055 - 1057, Retrieved from the Internet <URL:https://www.ttbz.org.cn/Home/WebDetail/31398> * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101569667A (en) | Medicament for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
CN103272177A (en) | Traditional Chinese medicine composition for treating bone fracture | |
CN105288230A (en) | Traditional Chinese medicine composition for treating paralysis | |
CN103463241A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation | |
CN104225508A (en) | Traditional Chinese medicine composition for cervical spondylosis treatment and preparation method thereof | |
CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
CN104606561A (en) | Traditional Chinese medicinal composition for treating spontaneous perspiration | |
CN109700856A (en) | A kind of Chinese medicine external prescription relieved pain with promoting blood circulation and removing obstruction in channels, relaxing muscles and tendons | |
CN116115677A (en) | Moxa stick for smart turtle moxibustion technology and preparation method thereof | |
CN103251754A (en) | Traditional Chinese medicine composition for treating bedsore | |
CN1063338C (en) | Traditional Chinese medicine preparation for curing cervical and lumbar hyperosteogeny | |
CN102579672A (en) | Medicament for treating bone hyperplasia and lumbar disc herniation | |
CN105748782A (en) | Traditional Chinese medicine oral liquid for treating cervical spondylosis | |
CN105267516A (en) | Plaster for skin surface local anesthesia | |
CN111437330A (en) | Composition for regulating menstruation and relieving pain, dispersible tablet, concentrated soft extract and preparation method thereof | |
CN110559417A (en) | gout-relieving moxibustion stick and preparation method thereof | |
CN104888133A (en) | Traditional Chinese medicine composition for treatment of coronary heart disease | |
CN104784417A (en) | Traditional Chinese medicine composition for curing impotentia | |
CN102068534B (en) | Chinese medicinal composition for relaxing tendons and activating collaterals and preparation method thereof | |
CN104547973A (en) | Health traditional Chinese medicine for treating chest obstruction and preparation method thereof | |
CN109620944B (en) | A Chinese medicinal composition with effects of dispelling pathogenic wind, removing dampness, strengthening tendons and bones, and its preparation method | |
CN105833152A (en) | Traditional Chinese medicine composition for treating endocrine dyscrasia | |
CN104758889A (en) | Traditional Chinese medicine composition for treating diabetes | |
CN104771529A (en) | Drug for treating traumatic arthritis caused by deficiencies in liver and kidney and preparation method thereof | |
CN115844972A (en) | Navel paste for treating osteoporosis and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |